Medicine
Showing 731-740 of 2,416 Results
-
Ruwan Gunaratne
Instructor, Medicine - Hematology
BioRuwan Gunaratne, MD, PhD is an Instructor in Hematology at Stanford University School of Medicine and a board-certified hematologist-oncologist with a clinical focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). His clinical and translational research centers on improving disease monitoring in myeloid cancers using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum. Dr. Gunaratne’s work has been recognized with awards from the American Society of Hematology and the Stanford Cancer Institute, and he is actively committed to advancing precision medicine approaches for patients with myeloid malignancies.
-
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on improving psychiatric care for medically complex patients through integrated behavioral health, medical education, and consultation-liaison psychiatry, with particular emphasis on psychiatry-led education for internal medicine residents, psychiatric interviewing, trauma-informed communication, delirium, catatonia, and psychopharmacology in the medically ill.
-
Neel K. Gupta
Clinical Associate Professor, Medicine - Oncology
Current Research and Scholarly InterestsI have specific interest in the pathobiology and management of individuals with AIDS-related and primary central nervous system lymphomas.
-
Shreya Gupta
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsI am a biomedical researcher focused on understanding the molecular mechanisms governing vascular smooth muscle cell (SMC) behavior in cardiovascular and metabolic diseases. My work investigates how signaling pathways, including Notch3 and Thrombospondin-1, regulate SMC phenotypic switching, fibrous cap stability, and plaque vulnerability in atherosclerosis, with the goal of identifying novel therapeutic targets to prevent heart attacks and strokes.
